SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-093947
Filing Date
2023-08-21
Accepted
2023-08-21 16:30:31
Documents
12
Period of Report
2023-08-16
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2324235d1_8k.htm   iXBRL 8-K 26047
  Complete submission text file 0001104659-23-093947.txt   197173

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clrb-20230816.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20230816_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20230816_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2324235d1_8k_htm.xml XML 3219
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 231189542
SIC: 2834 Pharmaceutical Preparations